I don't know of any. Aptamers can be easily modified chemically with a variety of functional groups and can bind to antibodies (this is used in the design of an aptamer-antibody hybrid sandwich ELISA), so while not trivial, I don't think it's impossible.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.